Eight teams at the edge of continuous hormone monitoring
From aptamer sensors to a fully implantable biochemical device — meet the 8 teams selected for SPRIND's €40M Continuous Hormone Monitoring Challenge.
Inside SPRIND’s jury for Continuous Hormone Monitoring
From wearable bioelectronics to metabolic research to decades of clinical obstetrics — the jury for SPRIND's Continuous Hormone Monitoring Challenge brings together an unusually wide range of expertise. Here's who's in the room, and where Edge Compliance fits in to assess regulatory strategy.
SPRIND's Continuous Hormone Monitoring Challenge open for applications
Hormones drive nearly every process in the body, yet we still measure them with single static snapshots. SPRIND's €40M Continuous Hormone Monitoring Challenge is funding sensor technology to change that — and I'll be on the jury selecting the founding teams. Here's what they're building, and why.
Optimised for the optimised
Health tech has never had more data or more capital — yet population health outcomes haven't moved. This article looks at why the wellness-to-medical staged strategy is harder than it looks, and what regulation, funding data, and public health theory tell us about who we're actually building for.
Plasters Vs Period Products
Why are tampons regulated differently than plasters? Discover the critical gap between "hygiene products" and Class I Medical Devices (MDR). From ISO 13485 quality standards and biocompatibility testing to the FDA’s Class II classification, we explore why medical-grade manufacturing—like Daye’s cleanroom production—is essential for menstrual safety.